Latest News

New Customer Service Number
Effective from Monday the 24th of January 2011, the contact details for Customer Services are changi... more...
28 January 2011
New 500 capsules unit packaging
Univar has been listening to the concerns of our German patients around the possibility of Univ... more...
15 April 2010
Trientine Compassionate Use Program
Univar Ltd is pleased to announce that with effect from March 1st 2010, qualified patients in design... more...
15 April 2010
Univar Ltd Supports Wilson's Disease awareness campaigns
Univar Ltd is committed to educating and increasing the awareness of Wilson's Disease, a very treata... more...
22 March 2010
May's News
News Archive

Wilson's Disease and Trientine Dihydrochloride

Wilson’s Disease, also known as hepatolenticular degeneration, is a rare inherited autosomal recessive disorder of copper metabolism, resulting in copper toxicity and dysfunction of several organs such as the liver, central nervous system, eyes and kidneys. The disease affects approximately 30 people in 1 million population.

Wilson's Disease is a very treatable condition. Trientine dihydrochloride, a chelating agent, is indicated for the treatment of Wilson’s disease in patients who are intolerant of D-Penicillamine therapy.
Univar Ltd has been manufacturing and supplying Trientine dihydrochloride for the treatment of Wilson's Disease patients since 1985.

 

This website is intended for information purposes only.

Each patient is strongly advised to consult with their physician about their individual cases.